• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β2-肾上腺素能受体信号调节代谢途径,这些途径对肿瘤微环境中髓源性抑制细胞的功能至关重要。

β2-adrenergic receptor signaling regulates metabolic pathways critical to myeloid-derived suppressor cell function within the TME.

机构信息

Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.

Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.

出版信息

Cell Rep. 2021 Oct 26;37(4):109883. doi: 10.1016/j.celrep.2021.109883.

DOI:10.1016/j.celrep.2021.109883
PMID:34706232
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8601406/
Abstract

Myeloid-derived suppressor cells (MDSCs) impede antitumor immunity; however, the precise mechanisms that regulate their suppressive function remain unresolved. Identifying these mechanisms could lead to therapeutic interventions to boost cancer immunotherapy efficacy. Here, we reveal that β2 adrenergic receptor (β2-AR) expression on MDSCs increases with tumor growth and that the β2-AR stress pathway drives the immune suppressive activity of MDSCs by altering their metabolism. We show that β2-AR signaling decreases glycolysis and increases oxidative phosphorylation and fatty acid oxidation (FAO). It also increases expression of the fatty acid transporter CPT1A, which is necessary for the FAO-mediated immunosuppressive function of MDSCs. Moreover, we show that β2-AR signaling increases autophagy and activates the arachidonic acid cycle, both required for increasing the release of the immunosuppressive mediator, PGE2. Our data reveal that β2-AR signaling triggered by stress is an important physiological regulator of key metabolic pathways in MDSCs, driving their immunosuppressive function.

摘要

髓源性抑制细胞 (MDSCs) 抑制抗肿瘤免疫;然而,调节其抑制功能的确切机制仍未解决。确定这些机制可能会导致治疗干预措施来提高癌症免疫治疗的效果。在这里,我们揭示了 MDSCs 上β2 肾上腺素能受体 (β2-AR) 的表达随着肿瘤的生长而增加,β2-AR 应激途径通过改变其代谢来驱动 MDSCs 的免疫抑制活性。我们表明,β2-AR 信号转导降低糖酵解并增加氧化磷酸化和脂肪酸氧化 (FAO)。它还增加了脂肪酸转运蛋白 CPT1A 的表达,CPT1A 对于 MDSCs 的 FAO 介导的免疫抑制功能是必需的。此外,我们表明β2-AR 信号转导增加自噬并激活花生四烯酸循环,这两者对于增加免疫抑制介质 PGE2 的释放都是必需的。我们的数据表明,应激引发的β2-AR 信号转导是 MDSCs 中关键代谢途径的重要生理调节剂,驱动其免疫抑制功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95c7/8601406/e28aabbaa1eb/nihms-1752051-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95c7/8601406/61fd817eed18/nihms-1752051-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95c7/8601406/734882a012a0/nihms-1752051-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95c7/8601406/00bb20bcef92/nihms-1752051-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95c7/8601406/cb601764522a/nihms-1752051-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95c7/8601406/e28aabbaa1eb/nihms-1752051-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95c7/8601406/61fd817eed18/nihms-1752051-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95c7/8601406/734882a012a0/nihms-1752051-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95c7/8601406/00bb20bcef92/nihms-1752051-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95c7/8601406/cb601764522a/nihms-1752051-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95c7/8601406/e28aabbaa1eb/nihms-1752051-f0006.jpg

相似文献

1
β2-adrenergic receptor signaling regulates metabolic pathways critical to myeloid-derived suppressor cell function within the TME.β2-肾上腺素能受体信号调节代谢途径,这些途径对肿瘤微环境中髓源性抑制细胞的功能至关重要。
Cell Rep. 2021 Oct 26;37(4):109883. doi: 10.1016/j.celrep.2021.109883.
2
Lipid Metabolic Pathways Confer the Immunosuppressive Function of Myeloid-Derived Suppressor Cells in Tumor.脂质代谢通路赋予髓源性抑制细胞在肿瘤中的免疫抑制功能。
Front Immunol. 2019 Jun 19;10:1399. doi: 10.3389/fimmu.2019.01399. eCollection 2019.
3
β2 adrenergic receptor-mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cells.β2 肾上腺素能受体介导的信号转导调节髓源性抑制细胞的免疫抑制潜力。
J Clin Invest. 2019 Dec 2;129(12):5537-5552. doi: 10.1172/JCI129502.
4
Metabolic Regulation of Myeloid-Derived Suppressor Cell Function in Cancer.癌症中髓源性抑制细胞功能的代谢调控。
Cells. 2020 Apr 18;9(4):1011. doi: 10.3390/cells9041011.
5
Connections between Metabolism and Epigenetic Modification in MDSCs.代谢与骨髓来源抑制细胞中表观遗传修饰的关联。
Int J Mol Sci. 2020 Oct 5;21(19):7356. doi: 10.3390/ijms21197356.
6
AMPK activation inhibits the functions of myeloid-derived suppressor cells (MDSC): impact on cancer and aging.AMPK 激活抑制髓系来源抑制细胞 (MDSC) 的功能:对癌症和衰老的影响。
J Mol Med (Berl). 2019 Aug;97(8):1049-1064. doi: 10.1007/s00109-019-01795-9. Epub 2019 May 25.
7
Chronic Adrenergic Stress Contributes to Metabolic Dysfunction and an Exhausted Phenotype in T Cells in the Tumor Microenvironment.慢性肾上腺素能应激导致肿瘤微环境中的 T 细胞代谢功能障碍和衰竭表型。
Cancer Immunol Res. 2021 Jun;9(6):651-664. doi: 10.1158/2326-6066.CIR-20-0445. Epub 2021 Mar 24.
8
Regulation of ROS in myeloid-derived suppressor cells through targeting fatty acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy.通过靶向脂肪酸转运蛋白 2 调节髓源性抑制细胞中的 ROS 增强抗 PD-L1 肿瘤免疫治疗。
Cell Immunol. 2021 Apr;362:104286. doi: 10.1016/j.cellimm.2021.104286. Epub 2021 Jan 19.
9
Repression of MUC1 Promotes Expansion and Suppressive Function of Myeloid-Derived Suppressor Cells in Pancreatic and Breast Cancer Murine Models.MUC1 的抑制促进了胰腺和乳腺癌小鼠模型中髓源性抑制细胞的扩增和抑制功能。
Int J Mol Sci. 2021 May 25;22(11):5587. doi: 10.3390/ijms22115587.
10
β-Adrenergic signaling blocks murine CD8 T-cell metabolic reprogramming during activation: a mechanism for immunosuppression by adrenergic stress.β-肾上腺素能信号阻断激活过程中小鼠 CD8 T 细胞的代谢重编程:应激肾上腺素能抑制免疫的一种机制。
Cancer Immunol Immunother. 2019 Jan;68(1):11-22. doi: 10.1007/s00262-018-2243-8. Epub 2018 Sep 18.

引用本文的文献

1
Neurotransmitters: an emerging target for therapeutic resistance to tumor immune checkpoint inhibitors.神经递质:肿瘤免疫检查点抑制剂治疗耐药性的一个新出现的靶点。
Mol Cancer. 2025 Aug 11;24(1):216. doi: 10.1186/s12943-025-02413-8.
2
Sympathetic nervous system in tumor progression and metabolic regulation: mechanisms and clinical potential.肿瘤进展和代谢调节中的交感神经系统:机制与临床潜力
J Transl Med. 2025 Jul 25;23(1):836. doi: 10.1186/s12967-025-06657-2.
3
Sympathetic neurosignaling in head and neck squamous cell carcinoma: bridging tumor biology, pain, and therapeutic innovation.

本文引用的文献

1
Chronic Adrenergic Stress Contributes to Metabolic Dysfunction and an Exhausted Phenotype in T Cells in the Tumor Microenvironment.慢性肾上腺素能应激导致肿瘤微环境中的 T 细胞代谢功能障碍和衰竭表型。
Cancer Immunol Res. 2021 Jun;9(6):651-664. doi: 10.1158/2326-6066.CIR-20-0445. Epub 2021 Mar 24.
2
MDSCs, ageing and inflammageing.骨髓来源抑制细胞、衰老和炎症老化。
Cell Immunol. 2021 Apr;362:104297. doi: 10.1016/j.cellimm.2021.104297. Epub 2021 Jan 30.
3
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity.
头颈部鳞状细胞癌中的交感神经信号传导:连接肿瘤生物学、疼痛与治疗创新
Med Oncol. 2025 Jul 15;42(8):334. doi: 10.1007/s12032-025-02911-1.
4
Neuro-immune cross-talk in cancer.癌症中的神经-免疫相互作用
Nat Rev Cancer. 2025 Jun 16. doi: 10.1038/s41568-025-00831-w.
5
Neuro-immune crosstalk in cancer: mechanisms and therapeutic implications.癌症中的神经-免疫相互作用:机制与治疗意义
Signal Transduct Target Ther. 2025 Jun 2;10(1):176. doi: 10.1038/s41392-025-02241-8.
6
Therapeutic and Prognostic Potential of G Protein-Coupled Receptors in Lung Adenocarcinoma: Evidence From Transcriptome Data and In Vitro Experiments.G蛋白偶联受体在肺腺癌中的治疗和预后潜力:来自转录组数据和体外实验的证据
Clin Respir J. 2025 May;19(5):e70080. doi: 10.1111/crj.70080.
7
Targeting nerve growth factor: an Achilles' heel for tumors?靶向神经生长因子:肿瘤的阿喀琉斯之踵?
J Immunother Cancer. 2025 May 2;13(5):e011609. doi: 10.1136/jitc-2025-011609.
8
Beta blocker use and breast cancer survival by subtypes: A population-based cohort study.β受体阻滞剂的使用与不同亚型乳腺癌的生存率:一项基于人群的队列研究。
Breast. 2025 Jun;81:104474. doi: 10.1016/j.breast.2025.104474. Epub 2025 Apr 8.
9
β-Arrestin 2 as a Prognostic Indicator and Immunomodulatory Factor in Multiple Myeloma.β-抑制蛋白2作为多发性骨髓瘤的预后指标和免疫调节因子
Cells. 2025 Mar 26;14(7):496. doi: 10.3390/cells14070496.
10
MDSC checkpoint blockade therapy: a new breakthrough point overcoming immunosuppression in cancer immunotherapy.髓源性抑制细胞(MDSC)检查点阻断疗法:癌症免疫治疗中克服免疫抑制的新突破点。
Cancer Gene Ther. 2025 Apr;32(4):371-392. doi: 10.1038/s41417-025-00886-9. Epub 2025 Mar 26.
在髓系细胞多样性不断增加的时代中的髓源性抑制细胞。
Nat Rev Immunol. 2021 Aug;21(8):485-498. doi: 10.1038/s41577-020-00490-y. Epub 2021 Feb 1.
4
Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor Activity.局部晚期和转移性黑色素瘤中联合应用普萘洛尔和派姆单抗的 I 期临床试验:安全性、耐受性和抗肿瘤活性的初步证据。
Clin Cancer Res. 2021 Jan 1;27(1):87-95. doi: 10.1158/1078-0432.CCR-20-2381. Epub 2020 Oct 30.
5
Stress reduction strategies in breast cancer: review of pharmacologic and non-pharmacologic based strategies.乳腺癌的减压策略:基于药理学和非药理学策略的综述。
Semin Immunopathol. 2020 Dec;42(6):719-734. doi: 10.1007/s00281-020-00815-y. Epub 2020 Sep 18.
6
Upregulation of CPT1A is essential for the tumor-promoting effect of adipocytes in colon cancer.CPT1A 的上调对于脂肪细胞在结肠癌中的促瘤作用是必不可少的。
Cell Death Dis. 2020 Sep 10;11(9):736. doi: 10.1038/s41419-020-02936-6.
7
Myeloid-Derived Suppressor Cells in Tumors: From Mechanisms to Antigen Specificity and Microenvironmental Regulation.肿瘤中的髓源性抑制细胞:从机制到抗原特异性和微环境调节。
Front Immunol. 2020 Jul 22;11:1371. doi: 10.3389/fimmu.2020.01371. eCollection 2020.
8
Autophagy regulates fatty acid availability for oxidative phosphorylation through mitochondria-endoplasmic reticulum contact sites.自噬通过线粒体-内质网接触位点调节脂肪酸氧化磷酸化的可用性。
Nat Commun. 2020 Aug 13;11(1):4056. doi: 10.1038/s41467-020-17882-2.
9
Defining the emergence of myeloid-derived suppressor cells in breast cancer using single-cell transcriptomics.利用单细胞转录组学定义乳腺癌中髓系来源抑制细胞的出现。
Sci Immunol. 2020 Feb 21;5(44). doi: 10.1126/sciimmunol.aay6017.
10
Perceptions of Stress: Patient and Caregiver Experiences With Stressors During Hospitalization.压力认知:患者和照护者在住院期间对压力源的体验。
Clin J Oncol Nurs. 2020 Feb 1;24(1):51-57. doi: 10.1188/20.CJON.51-57.